Basic Levitra With Dapoxetine Information

• INN (International Nonproprietary Name): Vardenafil With Dapoxetine — Vardenafil (for erectile dysfunction, ED) and Dapoxetine (for premature ejaculation, PE) are the respective INNs and are commonly combined in single‑tablet products sold under various brand names in some markets.
• Brand Names Available In United Kingdom: Not Specified — the fixed‑dose combination has no UK marketing authorisation and is not licensed by the MHRA; brands seen on international markets include Super Levitra, Levitra With Dapoxetine, Vardenafil+Dapoxetine and Super Vilitra.
• ATC Code: Vardenafil G04BE09; Dapoxetine G04BX14 — vardenafil is a PDE5 inhibitor and dapoxetine is classified as a short‑acting SSRI in the urologicals subcategory (ATC G04).
• Forms & Dosages: Film‑coated Tablets — commonly sold as 20 mg Vardenafil/60 mg Dapoxetine and 40 mg Vardenafil/60 mg Dapoxetine in blister packs of 4, 10 or 20 tablets.
• Manufacturers In United Kingdom: Not Specified — manufacturers listed in available product data are predominantly Indian (Sunrise Remedies, Centurion Laboratories, Healing Pharma) and Chinese exporters; no UK manufacturer holds a marketing authorisation for the fixed combination.
• Registration Status In United Kingdom: No UK Marketing Authorisation — the product is not centrally authorised by EMA nor approved by the FDA, and supply in the UK is through unlicensed imports or international e‑pharmacies where available.
• OTC / Rx Classification: Prescription‑Only (Rx) — the combination is prescription‑only in markets where it is sold and should not be considered an over‑the‑counter product.

Key Findings From Recent Trials

Major 2022–2025 Studies

What Have Trials Actually Shown?

High‑quality, large randomised controlled trials specifically testing the fixed‑dose vardenafil plus dapoxetine tablet are sparse up to 2025.

Most robust evidence comes from separate RCTs that established vardenafil for erectile dysfunction and dapoxetine for premature ejaculation as individual agents.

Data on the fixed‑dose tablet come mainly from smaller open‑label combination series, post‑marketing reports and clinician case series from markets such as India and parts of the CIS.

Trend data from 2022–25 indicate clinician interest in using PDE5 inhibitors together with on‑demand dapoxetine to manage mixed ED and PE, rather than a regulatory‑grade trial programme for the fixed tablet.

Main Outcomes

What Benefits Were Reported?

Pooled findings from small combination studies and case series show improved intercourse success rates and longer intravaginal ejaculatory latency time versus baseline in men treated with both agents together.

Greater benefit was consistently noted in men who presented with both erectile dysfunction and premature ejaculation compared with those who had PE alone.

Because large RCTs of the fixed‑dose product are lacking, these outcomes should be interpreted in the context of limited sample sizes and open‑label designs.

Safety Observations

What Safety Signals Emerged?

Reports flagged transient dizziness and syncope as more commonly reported when a vasodilator such as vardenafil is combined with other agents or consumed with alcohol.

Cases describing serotonin‑related adverse events have been isolated and usually occurred when dapoxetine was co‑prescribed with other serotonergic medicines.

Regulators in Western markets have not evaluated the fixed combination formally, so UK prescribers rely on individual component data and cautionary pharmacovigilance registries.

Clinical Mechanism Of Action

Layman’s Explanation

How Does The Combination Work In Plain Terms?

Vardenafil helps the penis fill with blood by relaxing blood vessels, which makes achieving and maintaining an erection easier when sexually stimulated.

Dapoxetine works on brain pathways that control ejaculation and temporarily increases serotonin activity to delay climax when taken before sex.

Taken together, a single tablet is intended to help with both erection quality and delaying ejaculation for a single sexual event.

Scientific Breakdown

What Happens At A Pharmacological Level?

Vardenafil is a selective PDE5 inhibitor (ATC G04BE09) that enhances cyclic GMP signalling in the corpus cavernosum, producing smooth muscle relaxation and improved penile tumescence during sexual stimulation.

Dapoxetine is a short‑acting selective serotonin reuptake inhibitor (ATC G04BX14) that increases serotoninergic neurotransmission in central pathways that mediate ejaculatory latency.

Typical pharmacokinetics are vardenafil Tmax about 0.5–2 hours and dapoxetine Tmax about 1–2 hours, with both drugs undergoing hepatic metabolism involving CYP enzymes; CYP3A4 inhibitors can raise drug exposures.

Mechanistic overlap creates clinical risks: combined vasodilation increases the potential for hypotension, and serotonergic effects raise the possibility of serotonin syndrome if other serotonergic drugs are present.

Scope Of Approved And Off‑Label Use

United Kingdom Approvals

Is The Fixed‑Dose Product Licensed In The UK?

The fixed‑dose vardenafil plus dapoxetine tablet does not have a UK marketing authorisation and is not centrally authorised by the EMA or approved by the FDA.

In UK clinical practice vardenafil and dapoxetine are available as separate prescription medicines, but fixed‑dose tablets such as Super Vilitra are not UK‑licensed and are effectively unlicensed imports when sourced here.

Notable Off‑Label Trends

How Do Patients Access It Elsewhere?

The fixed‑dose tablet is legally marketed in India and sold via international e‑pharmacies under brand names such as Super Vilitra and equivalents from other manufacturers.

Some UK patients source the combination online, and clinicians will occasionally encounter requests for the fixed tablet despite lack of UK authorisation.

Guidance in the UK advises prescribing licensed individual components rather than unlicensed fixed combinations to maintain quality and enable pharmacovigilance.

Dosage Strategy

General Dosing

What Is The Typical Regimen?

Common commercial strengths are 20 mg vardenafil with 60 mg dapoxetine and 40 mg vardenafil with 60 mg dapoxetine, most often in blisters of 4, 10 or 20 tablets.

The usual instruction where the product is used is a single tablet taken 30–60 minutes before sexual activity, not exceeding one tablet in 24 hours.

Condition‑Specific Dosing

How Do Clinicians Choose A Strength?

For men with both ED and PE, the 20 mg/60 mg strength is commonly used on‑demand and is the standard starting point in the available product literature.

Where response is inadequate, some clinicians consider the 40 mg/60 mg option, but evidence for benefit at higher vardenafil doses in the fixed tablet is limited and adverse effects rise.

Patients who are elderly or have hepatic or renal impairment should be started cautiously or avoid the fixed product where moderate to severe impairment is present, per product guidance.

Children and adolescents must not use these medicines.

In UK practice prescribers should prefer licensed separate agents to retain dose flexibility and safer monitoring.

Safety Protocols

Contraindications

Who Must Not Take This Medicine?

Absolute contraindications include known hypersensitivity to either component, concurrent nitrate therapy, recent myocardial infarction or stroke, severe heart failure, moderate to severe hepatic or renal impairment, and age under 18 years.

Concurrent use with SSRIs, MAOIs or thioridazine is contraindicated because of serotonergic risk and specific safety concerns.

Relative contraindications where close monitoring is needed include cardiovascular disease, bleeding disorders, conditions that predispose to priapism such as sickle cell disease, psychiatric history, and concomitant CYP3A4 inhibitors or alpha‑blockers.

Adverse Effects

What Side Effects Are Common Or Serious?

Common side effects reflect the combined profile: headache, flushing, dizziness, nasal congestion and vision changes from vardenafil, and nausea, diarrhoea, insomnia and anxiety from dapoxetine.

Serious risks include profound hypotension when combined with nitrates or alpha‑blockers, serotonin syndrome when added to other serotonergic agents, and priapism requiring urgent treatment.

Before prescribing in the UK, clinicians should perform a cardiovascular risk assessment and medication reconciliation to reduce avoidable harm.

Interaction Mapping

Food Interactions

Do Meals Or Alcohol Affect The Drugs?

High‑fat meals can delay absorption of vardenafil and may modestly affect dapoxetine absorption, so counsel patients on timing relative to food.

Alcohol increases the chance of dizziness, orthostatic hypotension and may worsen dapoxetine‑related nausea or dizziness, so advise patients to limit alcohol around dosing.

Drug Combinations To Avoid

Which Drug Combinations Are Dangerous?

Absolute avoidances are nitrates because of severe hypotension and MAOIs or other potent serotonergic medications because of serotonin syndrome risk.

Strong CYP3A4 inhibitors such as ritonavir or ketoconazole raise vardenafil levels and can increase adverse events; use caution or avoid fixed‑dose formulations when these are present.

Concomitant alpha‑blockers increase orthostatic hypotension risk and chronic SSRIs or SNRIs may already affect ejaculation, so adding on‑demand dapoxetine raises the serotonergic load.

In UK practice, always reconcile a patient’s medicines via GP or community pharmacy before advising on combined use.

Patient Experience Analysis

Survey Data

What Do Patients Say In Studies?

There are few peer‑reviewed surveys specific to fixed‑dose vardenafil plus dapoxetine, but broader surveys of men with mixed ED and PE show a preference for single‑dose regimens that simplify timing and reduce pill burden.

When both symptoms are treated, patients commonly report increased sexual confidence and satisfaction, according to existing patient‑reported outcome studies of separate agents and small combination series.

Forum Trends

What Are People Saying Online?

Online forums and e‑pharmacy reviews from markets where the product is sold report perceived efficacy but also frequent comments about side effects such as dizziness and nausea.

Users often express concerns about authenticity, inconsistent packaging and the absence of local regulatory oversight when buying abroad.

Clinicians in the UK report that patients who source unlicensed tablets online cite cost and convenience, yet prescribers are reluctant to recommend unlicensed imports because of quality and pharmacovigilance gaps.

Distribution And Pricing Landscape

Where Does The Product Come From And How Much Does It Cost?

Manufacture is predominantly in India, with brands such as Super Vilitra (Sunrise Remedies) and other producers and private‑label suppliers in China and India providing the tablets for export.

In the EU and UK the fixed‑dose tablet appears mainly via parallel importers and international e‑pharmacies and is not centrally authorised by EMA.

Retail pricing varies widely by market, pack size and source, and online sellers often list lower per‑tablet prices than branded single agents, which fuels demand despite quality concerns.

Lower price can correlate with greater risk from repackaging, labelling variation and non‑standard storage during shipment.

Patients should be advised that in our online pharmacy levitra with dapoxetine is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.

Alternative Options

Comparison Summary

What Are The Practical Alternatives For UK Patients?

Options include prescribing separate licensed agents concurrently — for example a licensed PDE5 inhibitor (vardenafil, sildenafil or tadalafil) plus dapoxetine where appropriate — or using alternative PDE5i combinations such as sildenafil with dapoxetine (marketed in some places as Super P‑Force).

Non‑pharmacological approaches such as cognitive behavioural therapy, behavioural techniques and pelvic floor physiotherapy are valid alternatives that target psychological and behavioural contributors to PE and ED.

Pros And Cons

How Do The Options Stack Up?

• Separate Licensed Prescriptions: Pros — regulated quality, UK pharmacovigilance and flexible dosing. Cons — more than one pill and coordination of timings.
• Fixed‑Dose Vardenafil+Dapoxetine: Pros — single‑pill convenience. Cons — not licensed in the UK, reduced ability to individualise dose, and supply/regulatory risks.
• Alternative PDE5i Choices: Pros — tadalafil gives longer duration for spontaneity. Cons — daily dosing strategies are not ideal with on‑demand dapoxetine.
• Non‑Drug Therapies: Pros — no systemic drug risks and address psychological factors. Cons — require time and specialist access, and benefits develop more slowly.

Regulatory Status

Who Has Approved It And What Does That Mean?

The combined tablet is sold in non‑Western markets but lacks central EMA authorisation and has no FDA approval.

Fetches from product information identify Indian manufacturers supplying Super Vilitra and similar labels, but no UK marketing authorisation exists for the fixed combination.

Supply to UK patients is either through unlicensed importation or parallel trade, which carries professional responsibilities for prescribers who choose to approve use.

Prescribing unlicensed products in the UK requires informed consent, clear documentation and justification for using the unlicensed product over licensed alternatives, with active adverse event reporting to MHRA through the Yellow Card scheme.

Consolidated FAQ

Common Questions Patients And Clinicians Ask

Is The Fixed‑Dose Tablet Legal In The UK?

No, it is not licensed in the UK and is only available as an unlicensed import or from international online sellers.

Is The Fixed Tablet Safer Than Taking Separate Pills?

Not necessarily; fixed doses remove flexibility and bypass UK regulatory oversight, which can increase risk compared with licensed, monitored prescriptions.

How Can Patients Reduce Risks?

Obtain licensed components through a GP or sexual health clinic, have a cardiovascular assessment, avoid prohibited drug combinations such as nitrates and MAOIs, and limit alcohol when dosing.

What Should Patients Do For Side Effects?

Stop taking the tablet and seek urgent medical attention for severe hypotension, chest pain, prolonged erection (priapism) or signs suggestive of serotonin syndrome such as agitation, tremor, hyperreflexia and hyperthermia.

How Should Clinicians Prescribe?

Prefer prescribing licensed vardenafil and dapoxetine separately to maintain quality assurance and monitoring, counsel on on‑demand use (max one tablet per 24 hours) and advise storing below 30°C in original packaging.

Visual Guide

How Can Patients And Clinicians Spot The Product And Stay Safe?

Front‑of‑pack identifiers most commonly include tablet markings showing both strengths, for example "20mg/60mg" or "40mg/60mg", and a film‑coated tablet appearance.

Packaging is usually blister cards of 4, 10 or 20 tablets and brand names to look for include Super Vilitra and Super Levitra, though spellings vary.

Authentication tips include checking for a named manufacturer (Sunrise Remedies, Centurion), batch numbers and expiry dates, and being wary of inconsistent spellings and poor print quality on labels.

Use this quick pre‑dose checklist at clinic visits: cardiovascular review, medication reconciliation for nitrates/SSRIs/MAOIs/CYP3A4 inhibitors, counsel on alcohol, advise dosing 30–60 minutes prior and emphasise max one tablet per 24 hours.

Follow simple adverse event actions: mild headache or flushing — symptomatic care; dizziness or fainting — stop and seek urgent review; priapism lasting over four hours — emergency urology referral.

Storage And Transport

How Should The Product Be Stored And What Are The Risks Of Importing?

Store below 30°C, protected from moisture and light, and keep in the original blister pack until use to maintain stability.

Postal transit from abroad can expose medicines to temperature and humidity variation, which may affect potency or appearance and is an additional risk for imported products.

UK pharmacies that accept patient‑supplied medicines should document provenance and ensure sealed packaging with batch and expiry details, while advising patients to return expired or unlabelled tablets for safe disposal.

Guidelines For Proper Use

What Are Practical Steps For Safe Prescribing And Follow‑Up?

Confirm both diagnoses with sexual history and validated scales where indicated, complete a cardiovascular assessment including blood pressure, and review all concomitant medicines before initiating therapy.

Prefer prescribing licensed agents separately in the UK to retain dosing flexibility and ensure pharmacovigilance.

If a patient presents having already bought a fixed‑dose tablet, perform medication reconciliation, counsel on contraindications and dosing (one tablet 30–60 minutes before sex, max one per 24 hours), and document informed consent.

Arrange follow‑up within two to four weeks to assess efficacy, tolerability and adherence, monitor for orthostatic symptoms, mood changes or priapism, and report adverse events to the MHRA Yellow Card scheme.

Delivery Across United Kingdom

Closing Notes For Clinicians And Patients

What Is The Bottom Line For UK Practice?

The evidence to 2025 for the fixed‑dose vardenafil plus dapoxetine tablet is limited to small series, pharmacovigilance reports and component‑level RCTs rather than large regulatory trials of the combination.

UK prescribers should favour licensed separate agents to preserve dosing options, quality control and pharmacovigilance oversight.

If a patient has chosen to import or has already obtained a fixed‑dose tablet, document discussion, perform a full medicines review and cardiovascular check, counsel on contraindications, and arrange timely follow‑up and Yellow Card reporting for any suspected adverse drug reactions.

Accessing treatment for ED and PE is common and manageable when done under clinical supervision, with safety checks and clear instructions on dosing and when to seek urgent care.